Beneficial effect of pre-transplant splenectomy for leukopenia in primary cadaver kidney transplants

J. M. Barry, B. Larson, S. M. Fischer, D. J. Norman, W. M. Bennett

Research output: Contribution to journalArticlepeer-review

Abstract

Pre-transplant splenectomy is controversial. We compared 21 nondiabetic, transfused recipients of first cadaver kidney grafts who underwent pre-transplant splenectomy for steroid-resistant leukopenia to 114 without steroid-resistant leukopenia. Kidney graft survivals at 2 years were 80.2 plus or minus 8.9 and 48.5 plus or minus 5.3 per cent, respectively (p < 0.05). The 2-year actuarial patient survivals were not significantly different (89.6 plus or minus 7.0 versus 87.8 plus or minus 3.9 per cent). Azathioprine doses and serum creatinine levels at 1 year were not significantly different. Pretransplant splenectomy for steroid-resistant leukopenia resulted in a significant decrease in kidney graft losses owing to rejection without an increased risk of death of sepsis or thromboembolism.

Original languageEnglish (US)
Pages (from-to)478-480
Number of pages3
JournalUnknown Journal
Volume129
Issue number3
StatePublished - Jan 1 1983

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Beneficial effect of pre-transplant splenectomy for leukopenia in primary cadaver kidney transplants'. Together they form a unique fingerprint.

Cite this